Investors.com http://ift.tt/1ELapXf What's the prescription for stirring up investor enthusiasm in the IPO market? INC Research Holdings (INCR) may have found the answer. INC is a contract research organization, or CRO, which provides phase one to phase four clinical development outsourcing services to the biopharma and medical device industries. It has a narrow therapeutic focus on oncology, central nervous system disorders and other complex diseases such as genetic disorders.
No comments:
Post a Comment